loader

nasdaq:imnm

LATEST ARTICLES

Immunome Announces Positive Topline Results from Phase 3 RINGSIDE Trial of Varegacestat in Patients with Desmoid Tumors

Immunome to Announce Topline Results from Phase 3 RINGSIDE Trial of Varegacestat in Patients with Desmoid Tumors

Immunome to Present at Upcoming Investor Conferences

Immunome Reports Third Quarter 2025 Financial Results and Provides Business Update

Immunome to Present at 2nd Annual Guggenheim Healthcare Innovation Conference

Immunome Presents Preclinical Data Showing Proprietary TOP1i ADC Payload HC74 Overcomes Multiple Mechanisms of ADC Resistance

Infinimmune Announces Research Collaboration with Immunome

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635

Immunome to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Immunome Inc.

Top NASDAQ Genetics Stocks

Top NASDAQ Genetics Stocks

Latest News

More News

Outlook Reports world

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES